This mutant exhibited dominant negative effects over WT glyt1, recapitulating the characteristics of the SLC6A9 missense variants identified in AIS patients (Figure 3, A and B, and Supplemental Figure 6, B–E). This evidence concerns the gene SLC6A9 and androgen insensitivity syndrome.